Delivery Order SPE2DB24D1205-SPE2DB25FCSST

Award Date 12/30/24
Potential Completion Date 12/31/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,031.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINEZOLID 100 MG/5 ML SUSP 150ML, a specialized pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of November 12, 2024. The contract is not designated as a set-aside and is an open competition award....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,250.90 firm fixed-price delivery order is for the supply of Linezolid 100 mg/5 ml suspension in 150 ml bottles. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,034.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,799,928 tablets of the antibiotic Linezolid 600 mg. The contract is a delivery order that runs through May 3, 2023, with a firm fixed price. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $13,929.10 with a firm fixed price pricing type and a completion date of January 21, 2025. The contract provides pharmaceutical products, including the ORSERDU 345 MG TABLET 30S, to support military treatment facilities, veterans' healthcare programs, and other federal medical...
This federal contract award is for medical supplies and pharmaceutical products provided by AmerisourceBergen Drug Corp to the Defense Logistics Agency (DLA). The $3,458.94 delivery order is for Linzess 290 MCG capsules and falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical division. This IDC, which runs through November 2026, enables the government to procure a wide range of pharmaceutical and medical commodities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,068.38 firm fixed-price delivery order is for pharmaceutical products, including a 30-count tablet medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,228.12 firm fixed-price delivery order is for the supply of various pharmaceutical and medical products to support military healthcare. The contract has an ultimate completion date of August 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,186.25 firm fixed-price delivery order has an ultimate completion date of January 3, 2025. The contract is not designated as a set-aside and provides for the delivery of a variety of pharmaceutical products and medical supplies to support military treatment...
This federal contract award, valued at $94,878.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zyvox 600mg tablets, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award, valued at $404,018.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCSST
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,525.41 firm fixed-price delivery order is for the supply of LINEZOLID 600 MG TABLET 20S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 3/31/25, 9:39 AM